Research News

Research News | Dec. 13, 2016

21st Century Cures Act Signed into Law

In a victory for research advocates, on December 13, President Barack Obama signed the 21st Century Cures Act into law.

Research News | Dec. 09, 2016

FDA Grants Fast Track Status for Neovacs’ study of IFNα Kinoid in Lupus

Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.

Research News | Dec. 07, 2016

LFA Praises Congress for Advancing 21st Century Cures Legislation

Over a year of advocacy efforts have paid off as the bill now moves to the President for signature.

Research News | Dec. 02, 2016

New Research!America Fact Sheet on Lupus

Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.

Research News | Nov. 15, 2016

LFA-Funded Study Helps Expedite Drug Development

This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.

Research News | Nov. 02, 2016

Aurina Announces Plans for Single Phase III Clinical Trial for Voclosporin

Aurinia Pharmaceuticals announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis.

Research News | Aug. 15, 2016

Phase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint

Trial results offer hope of a more effective and tolerable treatment option to manage lupus-related kidney disease.

Research News | Jul. 19, 2016

New promising study results: Cognitive impairment in kids with lupus

Neuropsychiatric lupus mainly affects children and young adults and can weaken cognitive functions. With a new non-invasive imaging technique, the damage can now be studied.